PDF herunterladen
Semin Liver Dis 2004; 24(1): 89-97
DOI: 10.1055/s-2004-823103
Copyright © 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Liver Biopsy Sampling in Chronic Viral Hepatitis

Maria Guido1 , 2 , Massimo Rugge2
  • 1Pathologist, Università Degli Studi di Padova, Azienda Ospedale, Padova, Italy
  • 2Dipartimento di Scienze Chirurgiche ed Oncologiche-Anatomia Patologica 2, Università Degli Studi di Padova, Azienda Ospedale, Padova, Italy
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
13. April 2004 (online)

    Lizenzen und Reprints

In chronic viral hepatitis, liver biopsy is performed to grade and stage liver damage. Liver biopsy samples are usually taken with a needle using a percutaneous procedure. This method produces a core of tissue representing approximately 1/50,000th of the liver mass, which raises concern about how representative a needle biopsy can be. A critical review of the literature reveals methodological limits unacceptable in this era of evidence-based medicine. Integrating earlier experience with more recently produced data indicates that a biopsy sample 2 cm or more in length containing at least 11 complete portal tracts should be reliable for grading and staging chronic viral hepatitis.

KEYWORDS

Liver biopsy - chronic hepatitis - viral hepatitis - histopathology - sampling error

REFERENCES

  • 1 von Frerichs F T. Uber den Diabetes. Berlin; Hirschwald 1884
    Google Scholar
  • 2 Menghini G. One-second needle biopsy of the liver.  Gastroenterology. 1958;  35 190-195
    PubMedGoogle Scholar
  • 3 Sherlock S, Dooley J. Diseases of the Liver and Biliary System, 4th ed. London; Blackwell Scientific 1997
    Google Scholar
  • 4 Van Leeuwen D J, Wilson L, Crowe D R. Liver biopsy in the mid-1990s: questions and answers.  Semin Liver Dis. 1995;  15 340-358
    PubMedGoogle Scholar
  • 5 Lebrec D. Various approaches to obtaining liver tissue: choosing the biopsy technique.  J Hepatol. 1996;  25 (Suppl 1) 20-24
    CrossrefPubMedGoogle Scholar
  • 6 Scheuer P J. Classification of chronic viral hepatitis: a need for a reassessment.  J Hepatol. 1991;  13 372-374
    CrossrefPubMedGoogle Scholar
  • 7 Schmid M, Flury R, Buhler H et al.. Chronic viral hepatitis B and C: an argument against the conventional classification of chronic hepatitis.  Virchows Arch. 1994;  425 221-226
    PubMedGoogle Scholar
  • 8 Ludwig J. The nomenclature of chronic active hepatitis: an obituary.  Gastroenterology. 1993;  105 274-278
    PubMedGoogle Scholar
  • 9 Batts K B, Ludwig J. Chronic hepatitis. An update on terminology and reporting.  Am J Surg Pathol. 1995;  19 1409-1417
    CrossrefPubMedGoogle Scholar
  • 10 Gerber M A. Chronic hepatitis C: the beginning of the end of a time honored nomenclature?.  Hepatology. 1992;  15 733-734
    PubMedGoogle Scholar
  • 11 Desmet V J, Gerber M, Hoofnagle J H et al.. Classification of chronic hepatitis: diagnosis, grading and staging.  Hepatology. 1994;  19 1513-1520
    CrossrefPubMedGoogle Scholar
  • 12 Brunt E M. Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond.  Hepatology. 2000;  31 241-246
    CrossrefPubMedGoogle Scholar
  • 13 Bravo A A, Sheth S G, Chopra S. Liver biopsy.  N Engl J Med. 2001;  344 495-500
    CrossrefPubMedGoogle Scholar
  • 14 Saadeh S, Cammell G, Carey W D et al.. The role of liver biopsy in chronic hepatitis C.  Hepatology. 2001;  33 196-200
    CrossrefPubMedGoogle Scholar
  • 15 Lok A S. Hepatitis B infection: Pathogenesis and management.  J Hepatol. 2000;  32 (Suppl 1) 89-97
    PubMedGoogle Scholar
  • 16 Booth J C, O'Grady J, Neuberger J. Clinical guidelines on the management of hepatitis C.  Gut. 2001;  49 (Suppl 1) 1-21
    CrossrefPubMedGoogle Scholar
  • 17 Dienstang J L. The role of liver biopsy in chronic hepatitis C.  Hepatology. 2002;  36 S152-S160
    CrossrefPubMedGoogle Scholar
  • 18 Knodell R G, Ishak K G, Black W C et al.. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.  Hepatology. 1981;  1 431-435
    CrossrefPubMedGoogle Scholar
  • 19 The French METAVIR Cooperative Study Group . Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C.  Hepatology. 1994;  20 15-20
    CrossrefPubMedGoogle Scholar
  • 20 Ishak K, Baptista A, Bianchi L et al.. Histological grading and staging of chronic hepatitis.  J Hepatol. 1995;  22 696-699
    CrossrefPubMedGoogle Scholar
  • 21 Guido M, Faa G. Morphological diagnosis of chronic hepatitis. Minimal requirements for histopathological referral [in Italian].  Pathologica. 1998;  90 176-182
    PubMedGoogle Scholar
  • 22 Goldin R D, Goldin G J, Burt A D et al.. Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis.  J Hepatol. 1996;  25 649-654
    CrossrefPubMedGoogle Scholar
  • 23 Westin J, Lagging L M, Weistal R et al.. Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection.  Liver. 1999;  19 183-187
    CrossrefPubMedGoogle Scholar
  • 24 Gronbaek K, Christensen P B, Hamilton-Dutoit S et al.. Interobserver variation in interpretation of serial liver biopsies from patients with chronic hepatits C.  J Viral Hepat. 2002;  9 443-449
    CrossrefPubMedGoogle Scholar
  • 25 Yano M, Kumada H, Kage M et al.. The long-term pathological evolution of chronic hepatitis C.  Hepatology. 1996;  23 1334-1340
    CrossrefPubMedGoogle Scholar
  • 26 Gebo K A, Herlong H F, Torbenson M S et al.. Role of liver biopsy in management of chronic hepatitis C: a systematic review.  Hepatology. 2002;  36 S161-S172
    CrossrefPubMedGoogle Scholar
  • 27 Zeuzem S, Feinman S V, Rasenack J et al.. Peg-interferon alpha-2a in patients with chronic hepatits C.  N Engl J Med. 2000;  343 1666-1672
    CrossrefPubMedGoogle Scholar
  • 28 Manns M P, Mc Hutchinson J G, Gordon S C et al.. Peg-interferon alpha 2b plus ribavirin compared with interferon alpha 2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial.  Lancet. 2001;  358 958-965
    CrossrefPubMedGoogle Scholar
  • 29 Saracco G, Ciancio A, Olivero A et al.. A randomized 4-arm multicenter study of interferon alpha -2b plus ribavirin in the treatment of patients with chronic hepatits C not responding to interferon alone.  Hepatology. 2001;  34 133-138
    CrossrefPubMedGoogle Scholar
  • 30 Shiratori I, Imazeki F, Moriyama M et al.. Histologic improvement of fibrosis in patients with hepatits C who have sustained response to interferon therapy.  Ann Intern Med. 2000;  132 517-524
    PubMedGoogle Scholar
  • 31 Oberti F, Valsesia E, Pilette C et al.. Non-invasive diagnosis of hepatic fibrosis and cirrhosis.  Gastroenterology. 1997;  113 1609-1616
    CrossrefPubMedGoogle Scholar
  • 32 Imbert-Bismut F, Ratziu V, Pieroni L et al.. Biochemical markers of liver fibrosis in patients with hepatits C virus infection: a prospective study.  Lancet. 2001;  357 1069-1075
    CrossrefPubMedGoogle Scholar
  • 33 Fontana R J, Lok A SF. Noninvasive monitoring of patients with chronic hepatitis C.  Hepatology. 2002;  36 S57-S64
    CrossrefPubMedGoogle Scholar
  • 34 Forns X, Ampurdanes S, Llovet J M et al.. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.  Hepatology. 2002;  36 986-992
    CrossrefPubMedGoogle Scholar
  • 35 Oh S, Afdhal N H. Hepatic fibrosis: are any of the serum markers really useful?.  Curr Gastroenterol Rep. 2001;  3 12-18
    PubMedGoogle Scholar
  • 36 Friedman S L. Liver fibrosis-from bench to bedside.  J Hepatol. 2003;  38 S38-S53
    PubMedGoogle Scholar
  • 37 Afdhal N H. Diagnosing fibrosis in hepatitis C: is the pendulum swinging from biopsy to blood tests?.  Hepatology. 2003;  37 972-974
    CrossrefPubMedGoogle Scholar
  • 38 Geller S A, Pitman M B. Morphological diagnostic procedures (liver biopsy). In: McSween RNM, Burt AD, Portmann BC, et al. Pathology of the Liver. London; Churchill Livingston 2002: 943-960
    Google Scholar
  • 39 Farrel R J, Smiddy P F, Pilkington R M et al.. Guided versus blind liver biopsy for chronic hepatis C: clinical benefits and costs.  J Hepatol. 1999;  30 580-587
    CrossrefPubMedGoogle Scholar
  • 40 Grant A, Neuberger J. Guidelines of the use of liver biopsy in clinical practice.  Gut. 1999;  45 (Suppl 1) 1-11
    PubMedGoogle Scholar
  • 41 Ahmad M, Riley T R. Can one predict when ultrasound will be useful with percutaneous liver biopsy?.  Am J Gastroenterol. 2001;  96 547-549
    CrossrefPubMedGoogle Scholar
  • 42 Lindor K D, Bru C, Jorgensen R A et al.. The role of ultrasonography and automatic-needle biopsy in outpatients percutaneous liver biopsy.  Hepatology. 1996;  23 1079-1083
    CrossrefPubMedGoogle Scholar
  • 43 Farrel R J, Smiddy P F, Pilkington R M et al.. Guided versus blind liver biopsy for chronic hepatis C: clinical benefits and costs.  J Hepatol. 1999;  30 580-587
    CrossrefPubMedGoogle Scholar
  • 44 Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies.  J Hepatol. 1986;  2 165-173
    CrossrefPubMedGoogle Scholar
  • 45 Demetris A J, Ruppert K. Pathologist's perspective on liver needle biopsy size?.  J Hepatol. 2003;  39 275-277
    CrossrefPubMedGoogle Scholar
  • 46 McGill D B, Rakela J, Zinsmeister A R, Ott B J. A 21-year experience with major hemorrhage after percutaneous liver biopsy.  Gastroenterology. 1990;  99 1396-1400
    PubMedGoogle Scholar
  • 47 Tobkes A I, Nord H J. Liver biopsy: review of methodology and complications.  Dig Dis. 1995;  13 267-274
    CrossrefPubMedGoogle Scholar
  • 48 Terjung B, Lemnitzer I, Ludwig-Dumoulin F et al.. Bleeding complications after percutaneous liver biopsy. An analysis of risk factors.  Digestion. 2003;  67 138-145
    CrossrefPubMedGoogle Scholar
  • 49 Froehlich F, Lamy O, Fried M, Gonvers J J. Practice and complication of liver biopsy: result of a national survey in Switzerland.  Dig Dis Sci. 1993;  38 1480-1484
    CrossrefPubMedGoogle Scholar
  • 50 McGill D B, Rakela J, Zinsmeister A R, Ott B J. A 21-year experience with major haemorrhage after percutaneous liver biopsy.  Gastroenterology. 1990;  99 1396-1400
    PubMedGoogle Scholar
  • 51 Jacobs W H, Goldberg S B. Statement on outpatient percutaneous liver biopsy.  Dig Dis Sci. 1989;  34 322-323
    CrossrefPubMedGoogle Scholar
  • 52 Nousbaum J B, Cadranel J F, Bonnemaison G et al.. Clinical practice guidelines on the use of liver biopsy.  Gastroenterol Clin Biol. 2002;  26 848-878
    PubMedGoogle Scholar
  • 53 Buckley A, Petrunia D. Practice guidelines for liver biopsy. Canadian Association of Gastroenterology.  Can J Gastroenterol. 2000;  14 481-482
    PubMedGoogle Scholar
  • 54 Shalm S W. The diagnosis of cirrhosis: clinical relevance and methodology.  J Hepatol. 1997;  27 1118-1119
    CrossrefPubMedGoogle Scholar
  • 55 Waldstein S, Szanto P B. Accuracy of sampling by needle biopsy in diffuse liver disease.  Arch Pathol. 1950;  50 326-329
    PubMedGoogle Scholar
  • 56 Soloway R D, Baggenstoss A H, Schoenfield L J, Summerskill W HJ. Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy.  Dig Dis Sci. 1971;  16 1082-1086
    PubMedGoogle Scholar
  • 57 Abdi W, Milln J C, Mezey E. Sampling variability on percutaneous liver biopsy.  Arch Intern Med. 1979;  139 667-669
    CrossrefPubMedGoogle Scholar
  • 58 Baunsgaard P, Sanchez G C, Lundborg C J. The variation of pathological changes in the liver evaluated by double biopsies.  Acta Pathol Microbiol Scand [A]. 1979;  87 51-57
    PubMedGoogle Scholar
  • 59 Maharaj B, Maharaj R J, Leary W P et al.. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver.  Lancet. 1986;  1 523-525
    PubMedGoogle Scholar
  • 60 Pagliaro L, Rinaldi F, Craxi A et al.. Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. A prospective, randomized trial.  Dig Dis Sci. 1983;  28 39-43
    CrossrefPubMedGoogle Scholar
  • 61 Poniachik J, Bernstein D E, Reddy K R et al.. The role of laparoscopy in the diagnosis of cirrhosis.  Gastrointest Endosc. 1996;  43 568-571
    CrossrefPubMedGoogle Scholar
  • 62 Scheuer P J, Lefkowitch J H. Liver Biopsy Interpretation 6th ed. Philadelphia; WB Saunders 2000
    Google Scholar
  • 63 Picciotto A, Ciravegna G, Lapertosa G, Celle G. Percutaneous or laparoscopic needle biopsy in the evaluation of chronic liver disease?.  Am J Gastroenterol. 1984;  79 567-568
    PubMedGoogle Scholar
  • 64 Gaiani S, Gramantieri L, Venturoli N et al.. What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy.  J Hepatol. 1997;  27 979-985
    CrossrefPubMedGoogle Scholar
  • 65 Fanning L, Loane J, Kenny-Walsh E et al.. Tissue viral load variability in chronic hepatitis C.  Am J Gastroenterol. 2001;  96 3384-3389
    CrossrefPubMedGoogle Scholar
  • 66 Regev A, Berho M, Jeffers L J et al.. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.  Am J Gastroenterol. 2002;  97 2614-2618
    CrossrefPubMedGoogle Scholar
  • 67 Persico M, Palmentieri B, Vecchione R et al.. Diagnosis of chronic liver disease: reproducibility and validation of liver biopsy.  Am J Gastroenterol. 2002;  97 491-492
    CrossrefPubMedGoogle Scholar
  • 68 Siddique I, El-Naga H A, Madda J P, Memon A, Hasan F. Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection.  Scand J Gastroenterol. 2003;  38 427-432
    CrossrefPubMedGoogle Scholar
  • 69 Holund B, Poulsen H, Schlichting P. Reproducibility of liver biopsy diagnosis in relation to the size of the specimen.  Scand J Gastroenterol. 1980;  15 329-335
    PubMedGoogle Scholar
  • 70 Schlichting P, Holund B, Poulsen H. Liver biopsy in chronic aggressive hepatitis. Diagnostic reproducibility in relation to size of specimen.  Scand J Gastroenterol. 1983;  18 27-32
    CrossrefPubMedGoogle Scholar
  • 71 Vargas-Tank L, Martinez V, Jiron M I et al.. Tru-Cut and Menghini needles: different yield in histological diagnosis of liver diseases.  Liver. 1985;  5 178-181
    PubMedGoogle Scholar
  • 72 Colombo M, Del Ninno E, De Franchis R et al.. Ultrasound-assisted percutaneous liver biopsy: superiority of the Tru-cut over the Menghini needle for diagnosis of cirrhosis.  Gastroenterology. 1988;  95 487-489
    CrossrefPubMedGoogle Scholar
  • 73 Rocken C, Meier H, Klauck S et al.. Large-needle biopsy versus thin-needle biopsy in diagnostic pathology of liver diseases.  Liver. 2001;  21 391-397
    CrossrefPubMedGoogle Scholar
  • 74 Petz D, Klauck S, Rohl F W et al.. Feasibility of histological grading and staging of chronic viral hepatitis using specimens obtained by thin-needle biopsy.  Virchows Arch. 2003;  442 238-244
    PubMedGoogle Scholar
  • 75 Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease.  J Hepatol. 2003;  39 239-244
    CrossrefPubMedGoogle Scholar
  • 76 Andriulli A, Annese V, Facciorusso D, Giacobbe A. First do no harm: power, oppression, and violence of liver biopsy.  Gastroenterology. 2003;  125 272-273
    PubMedGoogle Scholar
  • 77 Green R M, Flamm S L. First do no harm: power, oppression, and violence of liver biopsy.  Gastroenterology. 2003;  125 273-274
    PubMedGoogle Scholar

Maria GuidoM.D. 

Istituto di Anatomia Patologica

Via Gabelli, 61, 35100 Padova, Italy

eMail: mguido@unipd.it